SCYX
Price
$0.84
Change
+$0.04 (+5.00%)
Updated
Aug 15 closing price
Capitalization
32.77M
81 days until earnings call
SGIOY
Price
$8.93
Change
+$0.03 (+0.34%)
Updated
Aug 15 closing price
Capitalization
15.19B
72 days until earnings call
Interact to see
Advertisement

SCYX vs SGIOY

Header iconSCYX vs SGIOY Comparison
Open Charts SCYX vs SGIOYBanner chart's image
SCYNEXIS
Price$0.84
Change+$0.04 (+5.00%)
Volume$106.24K
Capitalization32.77M
Shionogi & Co
Price$8.93
Change+$0.03 (+0.34%)
Volume$99.16K
Capitalization15.19B
SCYX vs SGIOY Comparison Chart in %
Loading...
SCYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGIOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SCYX vs. SGIOY commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SCYX is a Hold and SGIOY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (SCYX: $0.84 vs. SGIOY: $8.93)
Brand notoriety: SCYX and SGIOY are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: SCYX: 56% vs. SGIOY: 128%
Market capitalization -- SCYX: $32.77M vs. SGIOY: $15.19B
SCYX [@Pharmaceuticals: Generic] is valued at $32.77M. SGIOY’s [@Pharmaceuticals: Generic] market capitalization is $15.19B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SCYX’s FA Score shows that 0 FA rating(s) are green whileSGIOY’s FA Score has 2 green FA rating(s).

  • SCYX’s FA Score: 0 green, 5 red.
  • SGIOY’s FA Score: 2 green, 3 red.
According to our system of comparison, SGIOY is a better buy in the long-term than SCYX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SCYX’s TA Score shows that 6 TA indicator(s) are bullish while SGIOY’s TA Score has 5 bullish TA indicator(s).

  • SCYX’s TA Score: 6 bullish, 4 bearish.
  • SGIOY’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SGIOY is a better buy in the short-term than SCYX.

Price Growth

SCYX (@Pharmaceuticals: Generic) experienced а -2.90% price change this week, while SGIOY (@Pharmaceuticals: Generic) price change was -0.22% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +4.25%. For the same industry, the average monthly price growth was +10.98%, and the average quarterly price growth was +78.05%.

Reported Earning Dates

SCYX is expected to report earnings on Nov 05, 2025.

SGIOY is expected to report earnings on Oct 27, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+4.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SGIOY($15.2B) has a higher market cap than SCYX($32.8M). SGIOY has higher P/E ratio than SCYX: SGIOY (13.12) vs SCYX (0.91). SGIOY YTD gains are higher at: 28.306 vs. SCYX (-30.587). SGIOY has higher annual earnings (EBITDA): 206B vs. SCYX (-26.67M). SGIOY has more cash in the bank: 576B vs. SCYX (40.6M). SCYX has less debt than SGIOY: SCYX (2.49M) vs SGIOY (11.7B). SGIOY has higher revenues than SCYX: SGIOY (419B) vs SCYX (2.63M).
SCYXSGIOYSCYX / SGIOY
Capitalization32.8M15.2B0%
EBITDA-26.67M206B-0%
Gain YTD-30.58728.306-108%
P/E Ratio0.9113.127%
Revenue2.63M419B0%
Total Cash40.6M576B0%
Total Debt2.49M11.7B0%
FUNDAMENTALS RATINGS
SCYX vs SGIOY: Fundamental Ratings
SCYX
SGIOY
OUTLOOK RATING
1..100
724
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
20
Undervalued
PROFIT vs RISK RATING
1..100
10099
SMR RATING
1..100
962
PRICE GROWTH RATING
1..100
6344
P/E GROWTH RATING
1..100
9840
SEASONALITY SCORE
1..100
1550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SGIOY's Valuation (20) in the null industry is in the same range as SCYX (45) in the Pharmaceuticals Other industry. This means that SGIOY’s stock grew similarly to SCYX’s over the last 12 months.

SGIOY's Profit vs Risk Rating (99) in the null industry is in the same range as SCYX (100) in the Pharmaceuticals Other industry. This means that SGIOY’s stock grew similarly to SCYX’s over the last 12 months.

SGIOY's SMR Rating (2) in the null industry is significantly better than the same rating for SCYX (96) in the Pharmaceuticals Other industry. This means that SGIOY’s stock grew significantly faster than SCYX’s over the last 12 months.

SGIOY's Price Growth Rating (44) in the null industry is in the same range as SCYX (63) in the Pharmaceuticals Other industry. This means that SGIOY’s stock grew similarly to SCYX’s over the last 12 months.

SGIOY's P/E Growth Rating (40) in the null industry is somewhat better than the same rating for SCYX (98) in the Pharmaceuticals Other industry. This means that SGIOY’s stock grew somewhat faster than SCYX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SCYXSGIOY
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
59%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
60%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
58%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
56%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
61%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
68%
Advances
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 4 days ago
65%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
50%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
SCYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGIOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PFIX55.451.27
+2.34%
Simplify Interest Rate Hedge ETF
KHPI25.59-0.02
-0.08%
Kensington Hedged Premium Income ETF
GJUL39.81-0.06
-0.15%
FT Vest U.S. Eq Mod Buffr ETF - Jul
NTSE34.38-0.10
-0.28%
WisdomTree Emerging Mkts Effcnt Cr ETF
ONEQ85.13-0.27
-0.32%
Fidelity Nasdaq Composite ETF

SCYX and

Correlation & Price change

A.I.dvisor tells us that SCYX and AKAN have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCYX and AKAN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCYX
1D Price
Change %
SCYX100%
+4.78%
AKAN - SCYX
32%
Poorly correlated
N/A
ELAN - SCYX
30%
Poorly correlated
-0.22%
AQST - SCYX
29%
Poorly correlated
N/A
CRDL - SCYX
28%
Poorly correlated
-2.24%
TLRY - SCYX
28%
Poorly correlated
-12.71%
More

SGIOY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGIOY has been loosely correlated with TAK. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SGIOY jumps, then TAK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGIOY
1D Price
Change %
SGIOY100%
+0.34%
TAK - SGIOY
40%
Loosely correlated
+1.35%
ESAIY - SGIOY
36%
Loosely correlated
+2.73%
KMDA - SGIOY
27%
Poorly correlated
+0.68%
SCYX - SGIOY
23%
Poorly correlated
+4.78%
SUPN - SGIOY
22%
Poorly correlated
+1.23%
More